Zydus' Nesher Pharma gets USFDA nod to market generic ADHD drug
Cadila Healthcare on Friday said Zydus' Nesher Pharmaceuticals has received final nod from the US health regulator to market generic version of Adder19-07-2019
19-07-2019
ZYDUS WELLNESS LTD.-$ - 531335 - Board Meeting Intimation for Notice For The Meeting Of Board Of Directors.
ZYDUS WELLNESS LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2019 ,inter alia, to consider and approve We hereby inform that a meeting of the Board of Directors of the Company will be held on Wednesday, July 31, 2019 to consider apart from other agenda items to approve the unaudited financial results for the quarter ended on June 30, 2019.16-07-2019
Zydus Wellness Ltd - 531335 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 201915-07-2019
Zydus Wellness Ltd - 531335 - Information Pursuant To Regulation 47 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper advertisements, published in Financial Express in English and Gujarati on July 8, 2019 regarding Notice of 25th Annual General Meeting, Remote E-voting information and Book Closure.08-07-2019
ZYDUS WELLNESS LTD.-$ - 531335 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Dhanraj P. DagarDesignation :- Company Secretary and Compliance Officer06-07-2019
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)06-07-2019
ZYDUS WELLNESS LTD.-$ - 531335 - Shareholding for the Period Ended June 30, 2019
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here06-07-2019
Zydus Wellness Ltd - 531335 - Reg. 34 (1) Annual Report
Annual General Meeting, Annual Report 2018-19 and Intimation of Record Date.02-07-2019
ZYDUS WELLNESS LTD.-$ - 531335 - Closure of Trading Window
Intimation of Closure of Trading Window.30-06-2019
Zydus Wellness Ltd - 531335 - Closure of Trading Window
Intimation of Closure of Trading Window.30-06-2019